Do you have any concerns about research overlap? Is there adequate collaboration on innovation with international institutions? For instance, in treating juvenile diabetes, we're investing in an artificial pancreas, and they have a parallel study in Australia. That's one example. I'm sure there is collaboration, but do you believe that we do enough of it?
On February 12th, 2013. See this statement in context.